These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16149177)

  • 21. Biomarkers, C-reactive proteins and statins in acute coronary syndromes.
    Ray KK
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():31-3. PubMed ID: 18001319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lp-PLA2: an emerging biomarker of coronary heart disease.
    Dada N; Kim NW; Wolfert RL
    Expert Rev Mol Diagn; 2002 Jan; 2(1):17-22. PubMed ID: 11963798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A2 and risk stratification for cardiovascular disease: not ready for "prime time".
    Steinberg DI; Mayer A
    Mayo Clin Proc; 2007 Feb; 82(2):155-7. PubMed ID: 17290719
    [No Abstract]   [Full Text] [Related]  

  • 24. Homocysteine predicts increased NT-pro-BNP through impaired fatty acid oxidation.
    Guéant Rodriguez RM; Spada R; Pooya S; Jeannesson E; Moreno Garcia MA; Anello G; Bosco P; Elia M; Romano A; Alberto JM; Juillière Y; Guéant JL
    Int J Cardiol; 2013 Aug; 167(3):768-75. PubMed ID: 22459404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
    Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease.
    Sajadieh A; Nielsen OW; Rasmussen V; Ole Hein H; Hansen JF
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1188-94. PubMed ID: 17100670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLAC test for identification of individuals at increased risk for coronary heart disease.
    Hoogeveen RC; Ballantyne CM
    Expert Rev Mol Diagn; 2005 Jan; 5(1):9-14. PubMed ID: 15723587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.
    Brilakis ES; McConnell JP; Lennon RJ; Elesber AA; Meyer JG; Berger PB
    Eur Heart J; 2005 Jan; 26(2):137-44. PubMed ID: 15618069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lp-PLA2: a new marker of vascular risk.
    Med Lett Drugs Ther; 2003 Oct; 45(1167):83. PubMed ID: 14534508
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
    Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
    Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
    Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
    J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The index and improvement effect of using Danhong injection to patients with atherosclerosis symptoms of coronary heart disease (CHD).
    Sun K; Fu C; Nie S; You Y
    Pak J Pharm Sci; 2014 Sep; 27(5 Suppl):1699-704. PubMed ID: 25262522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary Symptoms.
    Wieshammer S; Dreyhaupt J; Müller D; Momm F; Jakob A
    Oncology; 2016; 90(3):143-50. PubMed ID: 26871423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study.
    Levy D; Hwang SJ; Kayalar A; Benjamin EJ; Vasan RS; Parise H; Larson MG; Wang TJ; Selhub J; Jacques PF; Vita JA; Keyes MJ; Mitchell GF
    Circulation; 2007 Jun; 115(24):3079-85. PubMed ID: 17533184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearing a path for new cardiac markers.
    Parham S
    CAP Today; 2005 Feb; 19(2):1, 48, 50 passim. PubMed ID: 15787104
    [No Abstract]   [Full Text] [Related]  

  • 37. Are multiple biomarker testing strategies ready for prime time in heart failure?
    Lee DS; Tu JV
    Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
    [No Abstract]   [Full Text] [Related]  

  • 38. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimarker approach with cystatin C, N-terminal pro-brain natriuretic peptide, C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes.
    Vieira C; Nabais S; Ramos V; Braga C; Gaspar A; Azevedo P; Álvares Pereira M; Salomé N; Correia A
    Rev Port Cardiol; 2014 Mar; 33(3):127-36. PubMed ID: 24674467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the role of alternative biomarkers for coronary heart disease?
    Garg A
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):289-93. PubMed ID: 21521314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.